CardieX Limited (CDX.AX)
- Previous Close
0.0630 - Open
0.0630 - Bid 0.0580 x 281200
- Ask 0.0580 x 14158300
- Day's Range
0.0560 - 0.0630 - 52 Week Range
0.0560 - 0.2997 - Volume
1,920,153 - Avg. Volume
351,011 - Market Cap (intraday)
17.356M - Beta (5Y Monthly) 1.52
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0600 - Earnings Date Feb 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
CardieX Limited designs, manufactures, and markets medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that measures arterial health by collecting digital vascular biomarkers using novel sensors. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables for home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.
cardiex.comRecent News: CDX.AX
Performance Overview: CDX.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CDX.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CDX.AX
Valuation Measures
Market Cap
17.36M
Enterprise Value
16.62M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.70
Price/Book (mrq)
799.39
Enterprise Value/Revenue
1.32
Enterprise Value/EBITDA
-1.95
Financial Highlights
Profitability and Income Statement
Profit Margin
-66.44%
Return on Assets (ttm)
-20.08%
Return on Equity (ttm)
-412.13%
Revenue (ttm)
14.16M
Net Income Avi to Common (ttm)
-9.41M
Diluted EPS (ttm)
-0.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
4.53M
Total Debt/Equity (mrq)
35,370.68%
Levered Free Cash Flow (ttm)
-481.63k
Company Insights: CDX.AX
CDX.AX does not have Company Insights